Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
about
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic reviewFeeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-α in the heart of the offspringRole of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategiesForkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathyMitochondrial dysfunction in diabetic cardiomyopathyProtective mechanisms of mitochondria and heart function in diabetesDiabetes and Clinical and Subclinical CVD.Diabetic cardiomyopathy: pathophysiology and clinical featuresArray lessons from the heart: focus on the genome and transcriptome of cardiomyopathies.Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathyEmerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidantsDiabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul studyHbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging.Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1Structural arrangement of the cardiac collagen fibers of healthy and diabetic dogs.Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus.Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapies3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 ratsManaging preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatmentStrategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulinThe association of comorbid depression with intensive care unit admission in patients with diabetes: a prospective cohort studySeven-year mortality in heart failure patients with undiagnosed diabetes: an observational studyPotential role of nuclear factor κB in diabetic cardiomyopathy.New insights into insulin resistance in the diabetic heart.IGF-2R-Gαq signaling and cardiac hypertrophy in the low-birth-weight lamb.The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failureHospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control studyDiabetic heart disease.Metabolic syndrome and risk for heart failure in middle-aged men.Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetesAlcohol and incident heart failure among middle-aged and elderly men: cohort of Swedish menPredictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes.The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.Intensity of statin therapy and new hospitalizations for heart failure in patients with type 2 diabetes.Early initiation of beta blockade in heart failure: issues and evidence.Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
P2860
Q22242077-AE93D76E-4B4A-4771-89C0-81564F71F3D7Q24635109-17D39A80-F100-493B-8EFE-677263A38BB3Q24656109-ADA6B069-19B6-4374-9F57-55FC4308C70FQ28080067-BE488557-FBCB-4EFE-A76B-A465BBD4614FQ28390863-C5128513-547A-4A8F-9CEC-D21F301E8FD4Q28395215-F513BA15-2AD9-4B77-B56C-13BCF92E8386Q30244573-98CF1F45-6587-400F-A8F1-66A07897924FQ30457504-CD26DB9A-DC21-43EB-B033-7C41822C6ED2Q31160132-85C8DE5A-FAEE-4DED-A330-FA677483D1A9Q33275319-06F4244D-CA6C-48E6-8EEC-FF71933DBDF6Q33572265-DA229CAE-00EE-4226-B8E2-3B5C03B1B879Q33678572-5D965313-F1D1-4CB8-B17A-B73178116C7EQ33766515-A1AA6565-E034-4D1C-B679-4CFCEA1DBC09Q33773230-CC1CCCEA-1655-455A-A5B4-71795110B1D5Q33790560-F1AD0CBC-13C3-46FC-993B-A244E04058B2Q33816171-17743BA9-96C8-44EE-8DEC-B2032399207DQ33870108-9684A289-C669-4F45-95EA-B9CE6A95EDF6Q33883706-9DC5BA43-D91A-4459-A47F-35AFFAAAD2BCQ33949425-82C3D1C5-288D-44DF-ACF4-7E3B8984FD25Q33987863-7F0F2E3F-E91B-4FF9-92B0-BB5E43A089A8Q34095380-18BB7FE0-3DBE-443A-8353-71FAAA37DA9EQ34517974-CCAE76FC-C347-4828-8984-C1DECF1D5A86Q34541875-A7C9C29E-136F-4784-898E-7C7839137A0EQ34620604-4C6E9293-D6D3-4E8D-A518-FB5CA88A7403Q34777524-34C6D795-B46C-4F1E-B3C6-EFE71E2EDB0BQ35073928-91334B9F-45B2-43B9-84AF-B65DBFDDDBE6Q35104570-47E431FD-2F78-4576-96DB-3DF6E769BDD4Q35243945-26EF9F66-02F9-4079-B4D1-5DA40C247792Q35275486-D19934E7-536B-4261-AA6F-3FA8F7FDF9B3Q35675582-8496313E-E8C0-477F-B4D5-CD245C7F533FQ35691976-3ED0932A-5980-477F-B641-53D16E116C25Q35771450-BBC5111A-71AC-4F9F-8599-3EE73980F490Q35772103-1E6DF784-32FC-4673-8FF5-0A3E5F452FE4Q35827889-9BA1DE30-B2F7-43E1-9018-586F21EA6F62Q35880924-70FE6229-2528-4B6C-BA9A-44E77F98308EQ36078196-6F326A5E-D0E6-445B-BB18-54E2612CA48EQ36165860-A99FEC29-9EF7-44A7-A6CA-1645F2C3F7D1Q36258368-65B4BD31-934D-47A2-89B6-C75B48EE55FDQ36287752-D6430508-789C-4869-8B48-34B12467FAB9Q36320281-3EBAAC4E-F7A6-40C0-8295-FA8087F7F261
P2860
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@ast
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@en
type
label
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@ast
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@en
prefLabel
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@ast
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@en
P1433
P1476
Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
@en
P2093
David S H Bell
P304
P356
10.2337/DIACARE.26.8.2433
P407
P577
2003-08-01T00:00:00Z